1. Home/
  2. Compounds/
  3. tanespimycin:bortezomib (250:1 mol/mol)

tanespimycin:bortezomib (250:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2tanespimycin:bortezomib (250:1 mol/mol)
PharmacoGx tanespimycin:bortezomib (250:1 mol/mol)

Cell lines tested with tanespimycin:bortezomib (250:1 mol/mol)

797 cell lines have been tested with this compound, using data from 1 dataset(s).
A549 lung CTRPv23
DU-145 prostate CTRPv22
AsPC-1 pancreas CTRPv22
NCI-H1869 lung CTRPv22
CCF-STTG1 central nervous system CTRPv22
OAW-28 ovary CTRPv22
HeLa cervix CTRPv22
LOXIMVI haematopoietic and lymphoid tissue CTRPv22
NCI-H520 lung CTRPv22
IGROV-1 ovary CTRPv22
Download CSV

Tissues tested with tanespimycin:bortezomib (250:1 mol/mol)

25 tissues have been tested with this compound, using data from 1 dataset(s).
lungCTRPv2142
haematopoietic and lymphoid tissueCTRPv2135
N/ACTRPv247
central nervous systemCTRPv245
skinCTRPv244
pancreasCTRPv240
large intestineCTRPv239
ovaryCTRPv238
breastCTRPv237
stomachCTRPv232
Download CSV
Download Data as CSV

Top molecular features associated with response to tanespimycin:bortezomib (250:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ZZZ3 CTRPv2 AAC 0.029 0.4
mRNA ZZEF1 CTRPv2 AAC -0.0034 0.9
mRNA ZYX CTRPv2 AAC 0.059 0.1
mRNA ZYG11B CTRPv2 AAC 0.028 0.5
mRNA ZYG11A CTRPv2 AAC 0.056 0.2
mRNA ZXDC CTRPv2 AAC 0.048 0.2
mRNA ZXDB CTRPv2 AAC 0.069 0.06
mRNA ZXDA CTRPv2 AAC 0.058 0.1
mRNA ZWINT CTRPv2 AAC 0.1 0.005
mRNA ZWILCH CTRPv2 AAC 0.068 0.07
Download CSV